- Home
- GORO vs ONCY Comparison
GORO vs ONCY Comparison
Compare GORO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORO
- ONCY
- Stock Information
- Founded
- GORO 1998
- ONCY 1998
- Country
- GORO United States
- ONCY Canada
- Employees
- GORO N/A
- ONCY N/A
- Industry
- GORO Precious Metals
- ONCY Pharmaceuticals and Biotechnology
- Sector
- GORO Basic Materials
- ONCY Health Care
- Exchange
- GORO Nasdaq
- ONCY Nasdaq
- Market Cap
- GORO 49.9M
- ONCY 49.2M
- IPO Year
- GORO N/A
- ONCY 1999
- Fundamental
- Price
- GORO $0.41
- ONCY $0.56
- Analyst Decision
- GORO Strong Buy
- ONCY Strong Buy
- Analyst Count
- GORO 1
- ONCY 3
- Target Price
- GORO $1.25
- ONCY $4.33
- AVG Volume (30 Days)
- GORO 1.8M
- ONCY 330.3K
- Earning Date
- GORO 04-08-2025
- ONCY 05-08-2025
- Dividend Yield
- GORO N/A
- ONCY N/A
- EPS Growth
- GORO N/A
- ONCY N/A
- EPS
- GORO N/A
- ONCY N/A
- Revenue
- GORO $65,726,000.00
- ONCY N/A
- Revenue This Year
- GORO $87.06
- ONCY N/A
- Revenue Next Year
- GORO $8.13
- ONCY N/A
- P/E Ratio
- GORO N/A
- ONCY N/A
- Revenue Growth
- GORO N/A
- ONCY N/A
- 52 Week Low
- GORO $0.12
- ONCY $0.47
- 52 Week High
- GORO $0.74
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- GORO 42.34
- ONCY 45.75
- Support Level
- GORO $0.36
- ONCY $0.47
- Resistance Level
- GORO $0.49
- ONCY $0.65
- Average True Range (ATR)
- GORO 0.06
- ONCY 0.05
- MACD
- GORO -0.01
- ONCY 0.01
- Stochastic Oscillator
- GORO 31.82
- ONCY 50.00
About GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.